In praise of povidone-iodine application in ophthalmology
- PMID: 37944600
- PMCID: PMC10978307
- DOI: 10.1016/j.survophthal.2023.11.002
In praise of povidone-iodine application in ophthalmology
Abstract
Polyvinyl pyrrolidone or povidone-iodine (PVP-I) is a water-soluble complex formed by the combination of iodine and a water-soluble polymer, polyvinyl pyrrolidone. This complex exerts bactericidal, fungicidal, and virucidal action by gradually releasing free iodine at the site of application to react with pathogens. In ophthalmology, PVP-I is used as a disinfectant and antiseptic agent for preoperative preparation of the skin and mucous membranes and for treating contaminated wounds. PVP-I has been shown to reduce effectively the risk of endophthalmitis in various ocular procedures, including cataract surgery and intravitreal injections; however, it has also been used in the treatment of conjunctivitis, keratitis, and endophthalmitis, with promising results especially in low-resource situations. PVP-I has been associated with complications such as postoperative eye pain, persistent corneal epithelial defects, ocular inflammation, and an attendant risk of keratitis. In cases of poor PVP-I tolerance, applying PVP-I at lower concentrations or using alternative antiseptics such as chlorhexidine should be considered. We provide an update on the efficacy of PVP-I in the prophylaxis and treatment of conjunctivitis, keratitis, and endophthalmitis and a comprehensive analysis of the current literature regarding the use of PVP-I in the management of these ocular conditions. Also, PVP-I-related adverse effects and toxicities and its alternatives are discussed. The goal is to present a thorough evaluation of the available evidence and to offer practical recommendations for clinicians regarding the therapeutic usage of PVP-I in ophthalmology.
Keywords: Conjunctivitis; Endophthalmitis; Eye; Keratitis; Ophthalmology; Polyvinyl pyrrolidone; Povidone-iodine.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest None.
References
-
- Ahmed Y, Scott IU, Pathengay A, et al.: Povidone-iodine for endophthalmitis prophylaxis. American journal of ophthalmology. 2014; 157:503–504 - PubMed
-
- Ali FS, Jenkins TL, Boparai RS, et al.: Aqueous chlorhexidine compared with povidone-iodine as ocular antisepsis before intravitreal injection: a randomized clinical trial. Ophthalmology Retina. 2021; 5:788–796 - PubMed
-
- Ali Z, Khadije D, Elahe A, et al.: Prophylaxis of ophthalmia neonatorum comparison of betadine, erythromycin and no prophylaxis. J Trop Pediatr. 2007; 53:388–392 - PubMed
-
- Apt L, Isenberg S, Yoshimori R, Paez JH: Chemical preparation of the eye in ophthalmic surgery: III. Effect of povidone-iodine on the conjunctiva. Archives of ophthalmology. 1984; 102:728–729 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
